HEPQUANT
HepQuant is a medical diagnostics company with a unique, patented, and patent-pending technology for assessing the liver function of patients with chronic liver disease.
HEPQUANT
Industry:
Biotechnology Health Care Health Diagnostics Life Science
Founded:
2007-01-01
Address:
Greenwood Village, Colorado, United States
Country:
United States
Website Url:
http://www.hepquant.com
Total Employee:
11+
Status:
Active
Contact:
+1 303 923 2242
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Endocardial Solutions
Designs and develops a minimally invasive diagnostic system.
GuardRX
GuardRX develops life saving drugs, vaccines, diagnostics products & services for neglected infectious diseases.
Nostix
Nostix LLC develops a non-invasive glucose monitor.
Current Employees Featured
Founder
Official Site Inspections
http://www.hepquant.com
- Host name: 164.90.247.83
- IP address: 164.90.247.83
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "HepQuant"
The Company - HEPQuant
HepQuant develops and markets advanced, minimally invasive, quantitative liver function tests to help healthcare providers manage patients with chronic liver disease more effectively. The HepQuant DuO Test is a blood-based, first-in …See details»
HepQuant - Crunchbase Company Profile & Funding
Organization. HepQuant . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... HepQuant is a medical diagnostics company with a unique, patented, and patent-pending …See details»
The Team - HEPQuant
Touraj Shokati, PhD, joined HepQuant in May 2024 as Vice President of Clinical Laboratory Affairs, where he oversees clinical laboratory operations and ensures compliance with …See details»
HepQuant Company Profile 2024: Valuation, Funding & Investors
HepQuant General Information Description. Manufacturer of medical diagnostic devices designed for liver testing support services. The company's products are investigational combination drug …See details»
HEPQuant - Org Chart, Teams, Culture & Jobs - The Org
View HEPQuant's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
HepQuant, LLC - LinkedIn
The HepQuant DuO Test delivers information about liver cell function and portal-systemic shunting, attributes of liver disease that are associated with clinical outcomes. HepQuant, LLC | 2,224 ...See details»
HepQuant - Crunchbase
HepQuant develops minimally invasive diagnostics for liver function.See details»
HepQuant - Contacts, Employees, Board Members, Advisors
HepQuant has 2 current employee profiles, including Managing Director of Business Operations Lisa Goggin. Lisa Goggin Managing Director of Business Operations Gregory T Everson …See details»
HepQuant Announces Additions to the Executive ... - Business Wire
Jun 13, 2023 HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team. Four seasoned executiSee details»
Contact Us - HEPQuant
HepQuant headquarters is located in the Denver Tech Center in Denver, Colorado. Our laboratory is located in the Anschutz medical campus. Highly regarded for its natural beauty, strong academic presence and active lifestyle, …See details»
Perspectum and HepQuant Announce Partnership to Bring a More …
Partnership Combines Imaging and Functional Assessment for Clinical Research. San Francisco, CA and Denver, CO – Nov. 1, 2021. Perspectum and HepQuant are proud to announce a …See details»
Perspectum and HepQuant Announce Partnership to Bring a More …
Nov 1, 2021 HepQuant’s products are investigational combination drug and in-vitro diagnostic devices and have not yet been evaluated or reviewed by the US Food and Drug Administration …See details»
Hepion Pharmaceuticals Announces Clinical Collaboration with …
May 3, 2022 HepQuant’s CEO and Chief Medical Officer, Greg Everson, MD commented, “The noninvasive, blood-based HepQuant SHUNT test of liver function and physiology addresses …See details»
HepQuant Results Presented while Attending the 72
Nov 16, 2021 Description: The HepQuant DSI was shown to predict the likelihood of finding any and large esophageal varices (p < 0.0001, p < 0.0001) in patients of mixed characteristics, …See details»
HepQuant Announces Additions to the Executive Leadership Team …
Denver, CO – June 13, 2023 – HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team. Four seasoned …See details»
Hepion Pharmaceuticals Announces Initiation of Dosing in
Sep 12, 2022 The trial is being conducted in collaboration with HepQuant, LLC, (“HepQuant”) and Summit Clinical Research (“Summit”), at up to 20 sites within Summit’s Integrated …See details»
Products & Services Overview - HEPQuant
HepQuant tests measure uptake of cholate by the liver to quantitate liver function and portal systemic shunting. Cholate uptake is a natural process that is specific to the liver. Results may …See details»
Hepion Pharmaceuticals Announces Clinical Collaboration with …
May 3, 2022 - HepQuant Evaluation Offers Sensitive Measurement of Hepatic Function and Correlation with Clinical Outcomes - - Dedicated Phase 2b Trial Supports Overarching NASH …See details»
News & Events - HEPQuant
November 15, 2024 - November 19, 2024 San Diego, CA AASLD, The Liver Meeting. HepQuant is excited that six abstracts, will be presented, three of which were deemed a Poster of …See details»